-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Endovascular therapy (EVT) is the standard treatment for patients with acute ischemic stroke in the anterior circulation caused by intracranial occlusion (LVO)
.
As with general strokes, most patients receiving EVT are older
Vascular Stroke
In studies that reflect daily clinical routines, the median age is even higher, varying between 713 and 75 years old
.
Stroke caused by LVO is not common in young patients (<50 years old).
Therefore, data on the outcome and underlying causes of these patients after EVT are limited
.
In a high-efficiency reperfusion collaborative meta-analysis evaluated in multiple intravascular stroke trials, 56% of 18 to 49-year-old patients in the intervention group had good results, compared with only 47% in the control group
The direction of the effect seems to favor EVT, although no statistical significance (adjusted odds together to 1.
36 [95% CI, 0.
75-2.
46])
.
There is very little literature that specifically studies EVT in young patients, and little is known about the outcome of these patients and the cause of stroke
statistics
In this way, Josje Brouwer and others of the University of Amsterdam explored the causes of stroke in young LVO stroke patients receiving EVT treatment at a large national Dutch stroke registration center
.
In addition, the clinical and radiological results after EVT in young and elderly patients were compared
Method
.
We used data from patients with anterior circulation great vessel occlusion stroke (March 2014 to November 2017).
thrombus
They enrolled 3256 patients, 310 (10%) were 18 to 49 years old
.
Compared with older patients, younger patients had a lower median score on the National Institutes of Health Stroke Scale (14 points vs.
The clinical outcome of young patients is better than that of elderly patients (acOR of the modified Rankin scale conversion: 1.
8 [95% CI, 1.
5-2.
2]; functional independence [modified Rankin scale score 0-2] 61 versus 39% [after adjustment The odds ratio is 2.
1[95%CI, 1.
6-2.
8]]; the mortality rate is 7% to 32%, and the adjusted odds ratio is 0.
2[95%CI, 0.
1-0.
3])
.
The incidence of symptomatic intracranial hemorrhage is lower in young patients (3% vs.
6%, adjusted odds ratio, 0.
5[95%CI, 0.
2-1.
00])
.
Successful reperfusion (Expanded Cerebral Infarction Thrombolysis Score 2b-3) did not differ between the groups
.
The time from onset to reperfusion is shorter in young patients
The important significance of this study is that it found that 10% of acute ischemic stroke patients undergoing endovascular thrombectomy are younger than 50 years old
.
Cardiac embolism and carotid artery dissection are common basic causes in young patients
.
One-third of the cases did not find the cause, indicating that more research is needed on the causes of stroke in young patients
.
Compared with elderly patients, younger patients have a better prognosis and a lower risk of symptomatic intracranial hemorrhage
.
10% of acute ischemic stroke patients undergoing endovascular thrombectomy are younger than 50 years old
.
Cardiac embolism and carotid artery dissection are common basic causes in young patients
Original source:
Brouwer J, Smaal JA, Emmer BJ, et al.
Endovascular Thrombectomy in Young Patients With Stroke: A MR CLEAN Registry Study .
Stroke.
Published online December 7, 2021:STROKEAHA.
120.
034033.
doi:10.
1161/STROKEAHA.
120.
034033
Endovascular Thrombectomy in Young Patients With Stroke: A MR CLEAN Registry Study in this message
